Mezzion Pharma Acquires Additional Sh...
페이지 정보
본문
[Alpha Biz= Reporter Kim Jisun] Mezzion Pharma announced on the 16th that it would acquire an additional 158 shares of its U.S. subsidiary, Mezzion Pharmaceuticals, for approximately 163.5 billion KRW. Mezzion Pharmaceuticals, a subsidiary of Mezzion, was established in the U.S. for the purpose of developing and selling new drugs.
Even after the acquisition, Mezzions ownership stake remains 100%. The acquisition method involves converting a loan receivable into capital, and the purpose of the acquisition is to improve financial stability.
관련기사
▶ Doosan Bobcat Announces Industry-Leading Shareholder Return Plan with 200 Billion KRW Buyback
▶ Hanwha Aerospace Appoints Michael Coulter to Strengthen Global Defense Business
▶ National Tax Service Launches Tax Audit on SK Telecom
▶ U.S. DOE Grants Final Approval for $13.8 Trillion Loan to SK On-Ford Joint Venture, BlueOval SK
▶ [경제용어 나들이] 글로벌 가치 사슬이 뭘까요? : 경제용어사전｜알파경제TV
/ 알파경제 Kim Jisun Reporter
관련링크
- 이전글"연말 대목 되찾자" 안간힘…위축된 소비 살아날까 24.12.17
- 다음글"먼저 구매하면 더 싸다" 백화점 업계 설 선물세트 사전 예약 판매 24.12.17
댓글목록
등록된 댓글이 없습니다.